Self-medication in time of pandemic: Covid-19

Authors

  • Pedro Javier Navarrete-Mejía Doctor en Salud Pública
  • Juan Carlos Velasco-Guerrero Doctor en Salud Pública; Médico Internista
  • Luis Loro-Chero Médico Emergenciólogo

DOI:

https://doi.org/10.35434/rcmhnaaa.2020.134.762

Keywords:

self-medication, pandemics, SARS virus

Abstract

Objetive. To know the characteristics of self-medication as a preventive or symptomatic treatment in the previous stage and against the COVID pandemic 19. Materials and methods: observational-descriptive study, 790 inhabitants of the districts of North Lima participated, both sexes, over 18 years, voluntary participation. A questionnaire was completed with sociodemographic variables, educational level, comorbidities, pre-pandemic self-medication, pandemic self-medication, health professional / technical condition, and drugs; analysis of descriptive data and student's t-tests, pearson's Chi square (significance level 95%). Results: mean age 40.87 years, 51.08% female, primary / secondary education in 61.0% of cases; comorbidities present, at the time of data collection, high blood pressure (15.4%), overweight / obesity (13.7%), diabetes (7.1%) and cancer (4.6%). The most widely consumed drugs, self-medicated, prior to the start of the pandemic, pain reliever (29.1%), anti-inflammatories (28.1%) and antibiotics (27.6%); during the pandemic, antibiotics / anti-inflammatories (39.2%), anti-inflammatory (30.9%), antibiotics (21.6%), ivermectin (5.7%) and ivermectin in combination with other drugs (2.6%). Increase in the number of women who self-medicate as a preventive measure or symptomatic treatment in a pandemic (p = 0.0001), a similar situation with people with overweight / obesity (p = 0.001) and cancer (p = 0.023). Conclusions: variables around self-medication changed, age decreased and the number of women increased. The frequency of drugs and type also changed, going from higher consumption of pain relievers and anti-inflammatory drugs to greater consumption of antibiotics / anti-inflammatory drugs and medications such as ivermectin (alone or in combination). Self-medication is a problem for health systems, even more so without the effect of drugs on the SRS Cov2 being known; The actions for compliance with the General Health Law No. 26842 should be strengthened, a stricter control of the aspects related to the sale of medicines is urgent.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Pedro Javier Navarrete-Mejía, Doctor en Salud Pública

  1. Universidad de San Martin de Porres, Lima, Perú.
  2. Universidad Continental, Lima, Perú.

Juan Carlos Velasco-Guerrero, Doctor en Salud Pública; Médico Internista

  1. Hospital Nacional Arzobispo Loayza, Lima, Perú.

Luis Loro-Chero, Médico Emergenciólogo

  1. Hospital Emergencia Ate Vitarte, Lima, Perú.

Published

2021-02-14

How to Cite

1.
Navarrete-Mejía PJ, Velasco-Guerrero JC, Loro-Chero L. Self-medication in time of pandemic: Covid-19. Rev. Cuerpo Med. HNAAA [Internet]. 2021 Feb. 14 [cited 2024 Jul. 3];13(4):350-5. Available from: https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/762

Issue

Section

Original Article

Recommended Articles